| mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
0.31 |
1e-09 |
| mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
1e-07 |
| mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.28 |
2e-07 |
| mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
| mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
9e-06 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.0003 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |